Literature DB >> 33077654

ERG11 Polymorphism in Voriconazole-Resistant Candida tropicalis: Weak Role of ERG11 Expression, Ergosterol Content, and Membrane Permeability.

Patricia Navarro-Rodríguez1, Loida López-Fernández1, Adela Martin-Vicente1, Josep Guarro1, Javier Capilla2.   

Abstract

Mutations in ERG11 were detected by gene sequencing and amino acid alignment in 18 Candida tropicalis strains with different degrees of sensitivity to voriconazole (VRC). ERG11 expression, sterol content, and membrane permeability were also evaluated. We report three missense mutations in ERG11 that resulted in resistance to VRC. The transcriptional levels of ERG11 as well as the ergosterol content and membrane permeability demonstrated no correlation to only a slight correlation with the obtained MIC values, but the data did suggest a tendency toward such a correlation.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  C. tropicaliszzm321990; ERG11zzm321990; Erg11 mutations; azole resistance; ergosterol; gene expression; voriconazole

Mesh:

Substances:

Year:  2020        PMID: 33077654      PMCID: PMC7927814          DOI: 10.1128/AAC.00325-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

3.  Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.

Authors:  C Orasch; O Marchetti; J Garbino; J Schrenzel; S Zimmerli; K Mühlethaler; G Pfyffer; C Ruef; J Fehr; R Zbinden; T Calandra; J Bille
Journal:  Clin Microbiol Infect       Date:  2013-12-12       Impact factor: 8.067

4.  Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.

Authors:  Maurizio Sanguinetti; Brunella Posteraro; Barbara Fiori; Stefania Ranno; Riccardo Torelli; Giovanni Fadda
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.

Authors:  B A Arthington-Skaggs; H Jradi; T Desai; C J Morrison
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption.

Authors:  F M Müller; K E Werner; M Kasai; A Francesconi; S J Chanock; T J Walsh
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.

Authors:  D Andes; K Marchillo; T Stamstad; R Conklin
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Effect of Voriconazole on Candida tropicalis Biofilms: Relation with ERG Genes Expression.

Authors:  Tânia Fernandes; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2016-06-03       Impact factor: 2.574

Review 9.  Epidemiology of candidaemia and invasive candidiasis. A changing face.

Authors:  Guillermo Quindós
Journal:  Rev Iberoam Micol       Date:  2013-11-19       Impact factor: 1.044

10.  Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability.

Authors:  Pedro Pais; Raquel Califórnia; Mónica Galocha; Romeu Viana; Mihaela Ola; Mafalda Cavalheiro; Azusa Takahashi-Nakaguchi; Hiroji Chibana; Geraldine Butler; Miguel C Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.